TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

RUVEMBRI

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

RUVEMBRI

ST13

US500000079397386

Classe

5, 42

Pedido

79397386

Registro

7813467

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

26

Atualização mais recente

03/04/2026

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

5, 42

Data de depósito

25/03/2024

Data de registro

03/06/2025

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

03/06/2025

Última transação

03/04/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

33

Localização do titular

FR

Examinador

ADORNO SANTOS, LUZ M.

Unidade examinadora

M20

Localização atual

FILE REPOSITORY (FRANCONIA)

Titulares e representantes

Titulares

BIOPHYTIS

Representantes

Molly Hunsinger Ladas & Parry LLP

Classificação técnica

Classes Nice

Classe 5Classe 42

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 5

Prescription medicine and over-the-counter pharmaceutical products for the treatment of neuromuscular diseases; sanitary products for medicine, namely, sanitary preparations for medical purposes; chemical preparations for medical or pharmaceutical use for the treatment of neuromuscular diseases; food for babies; medical plasters, material for dressings, namely, sterile gauze dressing pads; materials for dental fillings and for making dental impressions; disinfectants; vitamins, vitamin-based preparations, dietetic substances for medical use, namely, dietetic preparations adapted for medical purposes; natural dietetic foods and remedy preparations based on medicinal plants adapted for medical or veterinary use for the treatment of neuromuscular diseases; dietetic beverages and foodstuffs adapted for medicinal use; food supplements and nutritional food additives for medicinal use in the nature of natural food extracts derived from fish, meat, vegetables, plants and herbs ; mineral food supplements for medicinal use; nutritional supplements, plant-based preparations in the nature of plant extracts, other than essential oils, for medicinal use; food supplements containing proteins, carbohydrates, lipids and/or fibers, or micronutrients such as vitamins and/or minerals, amino acids and/or fatty acids, for medical use; medicinal herbal extracts, other than essential oils, for medicinal purposes; preparations for making dietetic and medicated beverages, namely, syrups for making meal replacement beverages adapted for medical use, vitamin supplement in tablet form for use in making an effervescent beverage when added to water; medicinal preparations for the treatment of neuromuscular diseases; chemical preparations for medicinal use for the treatment of neuromuscular diseases; medicated candy and confectionery for medicinal use; pharmacological preparations for skin care

Classe 42

Scientific and technological services, namely chemical research, biological research and pharmaceutical research; research and development of new products for others; design and development of software and databases in the field of health; clinical studies, namely, scientific study services in the field of medicine, the prevention, treatment and management of neuromuscular diseases; scientific information services by providing scientific data in the field of pharmaceuticals; research in the field of pharmaceutical products; biological, clinical and medical research in the field of neuromuscular diseases; biotechnological research; scientific research for medical purposes in the field of neuromuscular diseases; computer-aided scientific research services in the field of neuromuscular diseases; information service concerning scientific research; preparation of reports concerning scientific research; advice relating to research and development in the therapeutic pharmaceuticals field; providing information and data with respect to medical and veterinary research and product development; conversion of computer programs and data, other than physical conversion; conversion of documents from a physical medium to an electronic medium

Publicações

Histórico de despachos e eventos da marca no USPTO.

26 publicações encontradas

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

22/01/2026

FICS

FINAL DISPOSITION NOTICE SENT TO IB

03/01/2026

FIMP

FINAL DISPOSITION PROCESSED

03/01/2026

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

30/11/2025

NREP

NEW REPRESENTATIVE AT IB RECEIVED

22/11/2025

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

12/11/2025

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

12/11/2025

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

03/09/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

03/06/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

03/06/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

15/04/2025

PUBO

PUBLISHED FOR OPPOSITION

15/04/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

09/04/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

17/03/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

19/02/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

19/02/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

19/02/2025

RFNT

REFUSAL PROCESSED BY IB

26/10/2024

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

10/10/2024

RFRR

REFUSAL PROCESSED BY MPU

10/10/2024

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

08/10/2024

CNRT

NON-FINAL ACTION WRITTEN

07/10/2024

DOCK

ASSIGNED TO EXAMINER

02/10/2024

MAFR

APPLICATION FILING RECEIPT MAILED

18/06/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

18/06/2024

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

13/06/2024

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace RUVEMBRI ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.